All News

Lungs ILD

RA ILD: Stepping out of the shadows

Richard Conway, MBBChBAO, PhD

Despite being relatively common and frequently severe, RA-ILD has been a neglected area of research and indeed of clinical management in RA. In recent years we finally seem to have started making some progress in this area and this momentum has continued with a several interesting abstracts at EULAR 2021. Here are four selected for review.

Read Article
COVID vaccine vials

Israel provides COVID vaccine answers for rheumatic disease patients

David Liew, FRACP

The question as to how autoimmune rheumatic disease patients fare with the COVID vaccine is one being asked in rheumatologists’ offices everywhere this year, and at the EULAR 2021 Virtual Congress, data presented from Israel, one of the first countries to vaccinate on a br

Read Article
joint.wrist_.pain_.CTS_.Carpal.jpg

RA after 70: Too Old for bioDMARDs?

Aurelie Najm, MD, PhD

In RA, the two most common peaks of incidence are thirties and fifties; however a significant percentage of patients above the age of 70 present with active RA -of early or later onset- and require adapted treatment.

Read Article
Video: Did I Forget Something? Dr. Jonathan Kay ( @RheumKay ) Dr. Jonathan Kay examines abstracts OP0216 and OP0215 that were presented at the virtual #EULAR2021 meeting. https://t.co/Vaa570r7WE https://t.co/mNQJyOiNep

Links:

Dr. John Cush RheumNow ( View Tweet)
Video: Impact of RA on Male Fertility: New Data: Dr. Aurelie Najm Dr. Aurelie Najm reviews abstracts OP0211 and OP0212 presented at the virtual #EULAR2021 meeting. https://t.co/AHwhyLiwD0 https://t.co/sm7cSBPIBV

Links:

Dr. John Cush RheumNow ( View Tweet)
Video: What Kind of Diet Should You be on? with Dr. Robert Chao ( @doctorRBC) https://t.co/jqkA8vrgww #EULAR2021 https://t.co/5mPuZWmw20

Links:

Dr. John Cush RheumNow ( View Tweet)
Video: RA and Cancer: Myth or Reality? Dr. Jonathan Kay ( @RheumKay ) Dr. Kay reviewed highlights from the "Oncorheumatology: the crossroads of cancer and musculoskeletal diseases" scientific session including abstract OP0187, presented at #EULAR2021. https://t.co/KaLEZ67L5S https://t.co/6MHXyffO2W

Links:

Dr. John Cush RheumNow ( View Tweet)
Video: The Future of Treatment of RA-ILD: Dr. David Liew ( @drdavidliew ) Dr. David Liew reviews abstract OP0124 presented at #EULAR2021 https://t.co/0dqBPRiwjA https://t.co/XR7cQhPVRw

Links:

Dr. John Cush RheumNow ( View Tweet)
RA after 70: Too Old for bioDMARDs? by Dr. Aurelie Najm #EULAR2021 In RA, the two most common peaks of incidence are 30s and 50s; however a significant % of patients in 70s present with active RA -of early or later onset- and require adapted treatment. https://t.co/w6rxT0FmlP https://t.co/fnvSQcu0Fl

Links:

Dr. John Cush RheumNow ( View Tweet)
Video: Difficult to Treat RA: Look out for Comorbidities: Dr. Aurelie Najm #EULAR2021 https://t.co/71Kx0HmmDm https://t.co/iu2p2EXNof

Links:

Dr. John Cush RheumNow ( View Tweet)
Clive Kelly presents data from INBUILD on nintedanib in progressive fibrosing RA-ILD over 52 weeks FVC decline -82.6 (41.3) mL in nintedanib vs -199.3 (36.2) mL in placebo (p=0.037) @RheumNow #EULAR2021 Abstr#OP0124 https://t.co/MZwzNoq6LC
Richard Conway RichardPAConway ( View Tweet)
⭐️JUNIPERA: RCT of SEC in active ERA & JPsA (2-18yo, most on MTX) -Tx . (TP)1: SEC 75/100 mg till wk 12 -TP2: cont SEC or switch to PBO till wk 104 ⭐️SEC efficacious on JIA ACR30/70 ⭐️74% w/ resolution of enthes ⭐️Median T2flare in PBO in TP2 = 453d LB0004 #EULAR2021 @Rheumnow https://t.co/JsG2pXz9r6
Meral K. El Ramahi, MD MeralElRamahiMD ( View Tweet)
What to tell pts about diet? *⃣Nutrition plays a role in inflammation in RMD & co-morbidities. What you eat matters! *⃣ LImit salt, replace w/ herbs *⃣ Consume low glycemic index foods. Soda ⬆️risk of RA in women *⃣⬆️omega-3 ⬇️omega-6 (dairy, eggs) #EULAR2021 @Rheumnow

Meral K. El Ramahi, MD MeralElRamahiMD ( View Tweet)

Baseline Vitamin D 😎☀️correlated with biologic response in RA pts. ⭐️EULAR good response: 19.6% Vit D >20 vs 4.2%⬇️Vit D ⭐️Remission: 14.4% ⬆️Vit D vs 3.2% ⬇️Vit D Abs#POS0100 #EULAR2021 @RheumNow

Robert B Chao, MD doctorRBC ( View Tweet)

MSK US before 1st clinic visit? Abs#POS0260 showed ⬇️ in time to diagnosis of inflammatory arthritis from 31 to 12 days and ⬇️clinical visits 2.8 to 2.1 How do you use MSK US in your clinic? #EULAR2021 @RheumNow

Robert B Chao, MD doctorRBC ( View Tweet)

6. Rheum disease activity was stable with COVID vaccination. (RA, PsA, axSpA, SLE - total n = 597) 7/ LB0003 #EULAR2021 @RheumNow https://t.co/xxkrunjPa0
David Liew drdavidliew ( View Tweet)
Treat-to-target is the robust algorithm that dictates all modern RA treatment. What's the target? Ummmm We use it in everyone, right? (both doctors & pts say 66%) We at least use the principles sometimes, right? (86% of us) [holds up mirror to self] POS0305 #EULAR2021 @RheumNow https://t.co/A9MXHMYbag
David Liew drdavidliew ( View Tweet)
On choosing an agent for MTX-IR RA: "(at the end of talk) My short answer could have been... there's no right or wrong. It's still one of the dilemmas we have in the treatment of RA: choosing the right drug for the right patient" - @DanielAletaha #EULAR2021 @RheumNow https://t.co/C45ey1SrA1
David Liew drdavidliew ( View Tweet)
I write more about this for @RheumNow - it’s powerful to know that AI can accurately tell the difference between RA, PsA, and healthy controls on the basis of the bony surface at MCP 2: https://t.co/ChDfihnW4f @LkasDer @maier_ak @FAU_Germany OP0145 #EULAR2021 (ping @DrCMcMaster) https://t.co/Pl7yxYfEqr

Links:

David Liew drdavidliew ( View Tweet)

EULAR 2021 - Day 2 Podcasts Check out this compilation of our EULAR 2021 Day 2 broadcasts below. You can also follow the EULAR 2021 RheumNow podcasts on iTunes and Soundcloud. https://t.co/GskToSkfLk https://t.co/nF2FkHgBtu

Links:

Dr. John Cush RheumNow ( View Tweet)
How well do you know this week's rheumatology news?
Take the rheumIQ quiz
Take the RheumIQ Quiz

×